Bebtelovimab
id:
bebtelovimab-239-1089198
title:
Bebtelovimab
text:
Bebtelovimab is a monoclonal antibody developed by AbCellera and Eli Lilly as a treatment for COVID-19. Possible side effects include itching, rash, infusion-related reactions, nausea and vomiting. Bebtelovimab works by binding to the spike protein of the virus that causes COVID-19, similar to other monoclonal antibodies that have been authorized for the treatment of high-risk people with mild to moderate COVID-19 and shown a benefit in reducing the risk of hospitalization or death. Bebtelovimab
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Bebtelovimab
date created:
date modified:
2023-12-01T20:34:17Z
main entity:
{"identifier":"Q110931681","url":"https://www.wikidata.org/entity/Q110931681"}
image:
fields total:
13
integrity:
14